Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,090 public trials 1,779 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)

NCT04993768

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • St. Joseph's Hospital and Medical Center, Barrow Neurological Institute Phoenix, Arizona, United States
  • UC San Diego Altman Clinical And Translational Research Institute La Jolla, California, United States
  • UCSF Neurosciences Clinical Research Unit (NCRU) San Francisco, California, United States
  • Rocky Mountain Movement Disorders Center Englewood, Colorado, United States
View all 14 locations
View Trial Details
Completed

Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

NCT06597058

Conditions
Alzheimer Disease, Amnesia, Brain Diseases, +16 more
Locations
  • Scottsdale Clinical Trials (Noah Clinical Site 017) Scottsdale, Arizona, United States
  • Marvel Clinical Research (Noah Clinical Site 010) Huntington Beach, California, United States
  • Accel Research Sites (Noah Clinical Site 019) DeLand, Florida, United States
  • Health Awareness (Noah Clinical Site 020) Jupiter, Florida, United States
View all 16 locations
View Trial Details
Completed

Bacillus Subtilis in Parkinson's Disease

NCT06487975

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Norwegian Centre for Movement Disorders, Stavanger University Hospital Stavanger, Norway
  • NHS Lothian Edinburgh, United Kingdom
View Trial Details
Completed

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

NCT02071459

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +12 more
Locations
  • Centre hospitalier d'Angers Angers, France
  • CHU bordeaux Bordeaux, France
  • CHU de Clermont-Ferrand Clermont-Ferrand, France
  • CHU de Dijon Dijon, France
View all 13 locations
View Trial Details
Completed

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

NCT05694819

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Chiba University Hospital Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Hospital Organization Kyushu Medical Center Fukuoka, Japan
View Trial Details

Related conditions